ALEXANDRIA, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ASCO ASSOCIATION, founded in 2019, is a mid-sized nonprofit in the Community Improvement sector that reported $17.4M in total revenue in fiscal year 2023. Revenue grew 13% year-over-year, indicating healthy expansion. Expenses of $15.1M left a modest 14% surplus.
ASCO ASSOCIATION PROMOTES THE COMMON BUSINESS INTERESTS OF ITS MEMBERS BY: (1) ADVOCATING FOR POLICIES THAT IMPROVE THE QUALITY OF CANCER CARE; (2) MAINTAINING THE HIGHEST STANDARDS OF ONCOLOGY MEDICAL CARE THROUGH PROGRAMS SUPPORTING EDUCATION, (CONTINUED IN SCHEDULE O) RESEARCH, AND QUALITY IMPROVEMENT; AND (3) INCREASING AWARENESS AMONG THE MEDICAL COMMUNITY, PATIENTS, AND THE PUBLIC OF CHALLENGES FACED BY ONCOLOGY MEDICAL PROFESSIONALS THAT MAY AFFECT QUALITY OF CANCER CARE.
:MEMBER SERVICES: THE ASSOCIATION WORKS TO SUPPORT AND EDUCATE ITS GLOBAL NETWORK OF NEARLY 45,000 ONCOLOGY PROFESSIONAL MEMBERS, MAINTAINING ONLINE FORUMS THAT ALLOW MEMBERS TO DISCUSS ISSUES OF...
:MEMBER SERVICES: THE ASSOCIATION WORKS TO SUPPORT AND EDUCATE ITS GLOBAL NETWORK OF NEARLY 45,000 ONCOLOGY PROFESSIONAL MEMBERS, MAINTAINING ONLINE FORUMS THAT ALLOW MEMBERS TO DISCUSS ISSUES OF PROFESSIONAL INTEREST, SUPPORTING INTERNATIONAL REGIONAL COUNCILS, AND RECRUITING MEMBERS FOR, AND TRACKING PARTICIPATION IN, VOLUNTEER ACTIVITIES RELATED TO THE ASSOCIATION, INCLUDING SERVING ON COMMITTEES.
:ACCREDITATION & CERTIFICATION: THE ASSOCIATION CONDUCTS AN ACCREDITATION PROGRAM THAT PROMOTES THE PRACTICE OF ITS MEMBERS BY MAINTAINING AND IMPROVING THE QUALITY OF MEDICAL CARE AVAILABLE TO THE...
:ACCREDITATION & CERTIFICATION: THE ASSOCIATION CONDUCTS AN ACCREDITATION PROGRAM THAT PROMOTES THE PRACTICE OF ITS MEMBERS BY MAINTAINING AND IMPROVING THE QUALITY OF MEDICAL CARE AVAILABLE TO THE PUBLIC AND MAINTAINING HIGH STANDARDS OF EXCELLENCE IN ONCOLOGY.THE QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) CERTIFICATION PROGRAM ("QCP") PROVIDES A THREE-YEAR CERTIFICATION RECOGNIZING HIGH-QUALITY AND SAFE CARE FOR OUTPATIENT HEMATOLOGY-ONCOLOGY PRACTICES. THE QCP STANDARDS WERE ADAPTED FROM THE CHEMOTHERAPY ADMINISTRATION SAFETY STANDARDS CODEVELOPED BY ASCO AND THE ONCOLOGY NURSING SOCIETY (ONS). THEY ARE INTENDED TO PROVIDE SAFTEY TO BOTH PATIENTS AND THE CARE DELIVERY STAFF BY REDUCING THE RISK OF ERRORS AND PROMOTING THE SAFE HANDLING OF CHEMOTHERAPY AGENTS. PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL QCP STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. QCP CERTIFICATION RECOGNIZES HIGH PERFORMING PRACTICES AND IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 273 HEMATOLGY-ONCOLOGY PRACTICES ARE ACTIVELY CERTIFIED IN 2023.THE ASSOCIATION LAUNCHED A NEW QUALITY CERTIFICATION PROGRAM IN 2023, ASCO CERTIFIED. THIS CERTIFICATION RECOGNIZES PATIENT CENTERD CANCER CARE DELIVERY ADHERING TO THE ONCOLOGY MEDICAL HOME STANDARDS CODEVELOPED BY ASCO AND THE COMMUNITY ONCOLGY ALLIANCE (COA). SIMILAR TO QCP, PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL ASCO CERTIFIED STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. ONCE CERTIFIED PARTICANTS ARE MONITORED ANNUALLY FOR CONTINUOUS QAUALITY IMPROVEMENT AND RESURVEYED EVERY 3 YEARS. ASCO CERTIFIED IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 12 HEMATOLOGY-ONCOLOGY PRACTICES ACHIEVED CERTIFICATION IN 2023.
:ADVOCACY: THE ASSOCIATION'S ADVOCACY WORK FOCUSES ON ASSURING HIGH-QUALITY CARE FOR ALL PATIENTS WITH CANCER. WORKING WITH VOLUNTEER MEMBERS AND AFFILIATED STATE AND REGIONAL ONCOLOGY SOCIETIES...
:ADVOCACY: THE ASSOCIATION'S ADVOCACY WORK FOCUSES ON ASSURING HIGH-QUALITY CARE FOR ALL PATIENTS WITH CANCER. WORKING WITH VOLUNTEER MEMBERS AND AFFILIATED STATE AND REGIONAL ONCOLOGY SOCIETIES, ASCO ENGAGES WITH THE ADMINISTRATION, CONGRESS, AND STATE LAWMAKERS TO ADDRESS ISSUES OF CRITICAL IMPORTANCE TO CANCER CARE AND RESEARCH. THE ASSOCIATION'S ADVOCACY PORTFOLIO INCLUDES CLINICAL RESEARCH, INSURANCE, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST AND ACCESS, SURVIVORSHIP, AND CANCER PREVENTION. ADVOCACY ACTIVITIES INCLUDE TRACKING, ANALYZING, AND INFLUENCING PENDING LEGISLATION AND REGULATIONS, AND EDUCATING BOTH MEMBERS AND POLICYMAKERS ABOUT THE IMPACT OF POLICY ON CANCER PATIENTS, CLINICIANS, AND CLINICAL RESEARCH. IN 2023, ASCO WAS INVITED TO TESTIFY BEFORE THE HOUSE ENERGY AND COMMERCE COMMITTEE, THE HOUSE WAYS AND MEANS COMMITTEE, AND THE SENATE FINANCE COMMITTEE ON ISSUE OF IMPORTANCE TO CANCER CARE AND RESEARCH, INCLUDING THE DRUG SHORTAGE CRISIS AND THE NEED TO SUSTAIN A NATIONAL RESEARCH ENTERPRISE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $17,408,296 | $15,448,005 | +0.1% |
| Expenses | $15,055,745 | $14,306,730 | +0.1% |
| Net Income | $2,352,551 | $1,141,275 | +1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| EVERETT E VOKES MD | BOARD CHAIR (PARTIAL YEAR) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LORI J PIERCE MD | BOARD CHAIR (PARTIAL YEAR) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRIAN EDWARD PERSING MD | TREASURER (PARTIAL YEAR) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JASON R WESTIN MD MS | TREASURER (PARTIAL YEAR) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ETHAN M BASCH MD MSC | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA A CAREY MD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| XYLINA T GREGG MD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| TARA O HENDERSON MD MPH | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| ELIZABETH A MITTENDORF MD PHD MHC | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| TAOFEEK K OWONIKOKO MD PHD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| ELIZABETH R PLIMACK MD MS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LYNN M SCHUCHTER MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ENRIQUE SOTO PEREZ DE CELIS MD MSC | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| PIYUSH SRIVASTAVA MD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL A THOMPSON MD PHD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| ERIC P WINER MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBIN ZON MD | BOARD MEMBER (PARTIAL YEAR) | 1.00 |
Director
|
$0 | $0 | $0 |
| CLIFFORD A HUDIS | CEO | 1.00 |
Officer
|
$0 | $24,750 | $1,085,551 |
| LINDA A JENSEN | CFO | 1.00 |
Officer
|
$0 | $42,792 | $520,324 |
| MELISSA TAI | SECRETARY | 8.00 |
Officer
|
$0 | $49,281 | $399,396 |
| KRISTA BARNES | VICE PRESIDENT, MEMBER SERVICES | 19.00 |
Key Emp
|
$302,663 | $47,169 | $349,832 |
| JENNIFER BRUNELLE | CHIEF ADVOCACY OFFICER | 37.50 |
Key Emp
|
$258,709 | $43,569 | $302,278 |
| KAREN HAGERTY | CHIEF REGULATORY AFFAIRS OFFICER | 37.50 |
Highest
|
$245,179 | $26,560 | $271,739 |
| RONDA BOWMAN | SENIOR DIRECTOR, QCP | 37.50 |
Highest
|
$213,046 | $30,341 | $243,387 |
| TERRY COX | DIRECTOR, AFFILIATE RELATIONS | 37.50 |
Highest
|
$161,700 | $30,417 | $192,117 |
| SHIMERE SHERWOOD | DIRECTOR, SCIENCE & RESEARCH POLICY | 37.50 |
Highest
|
$174,380 | $12,375 | $186,755 |
| KRISTINE RUFENER | DIRECTOR, CONGRESSIONAL AFFAIRS | 37.50 |
Highest
|
$161,472 | $37,044 | $198,516 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $17,408,296 | $15,055,745 | $5,377,567 | $2,352,551 |
| 2022 | $15,448,005 | $14,306,730 | $4,082,175 | $1,141,275 |
| 2021 | $14,262,965 | $12,531,043 | $7,233,977 | $1,731,922 |
| 2020 | $14,116,561 | $15,004,212 | $5,491,917 | $-887,651 |
Compare ASCO ASSOCIATION with other nonprofits in Virginia and across the country.